SANTA BARBARA, CA , Nov. 13, 2020 (GLOBE NEWSWIRE) -- SunHydrogen, Inc. (OTC: HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and water, today has announced an adjustment to the manufacturing process that will extend the lifetime of the hydrogen producing solar cell assembly by using a new combination of polymers to protect the device from photocorrosion of the solar cells. While the upgrade has caused a delay in production, the outcome has been a considerably improved product and process. The 100 demonstration panels are now back in full manufacturing mode.
Nov 13 2020
SunHydrogen Improves Hydrogen Production Device in Manufacturing Process
MUNICH, Germany, Nov. 10, 2020 (GLOBE NEWSWIRE) -- CatalYm GmbH, a biopharmaceutical company developing novel cancer immunotherapies, today announced the closing of its EUR50 million Series B financing round. The financing was led by Vesalius Biocapital III and joined by Novartis Venture Fund (NVF), Wachstumsfonds Bayern, coparion and founding investors Forbion and BioGeneration Ventures. Representatives from Vesalius Biocapital III, NVF and Wachstumsfonds Bayern will join the Board.
Nov 10 2020
CatalYm raises EUR50 million to advance GDF-15 antibody into clinical trials for checkpoint-inhibitor refractory patients
Cottonwood Technology Fund is a venture capital and private equity company that is willing to invest in companies in the pre-revenue/pre-product stage. The VC firm invests in sectors including nanotechnology, robotics, and the automotive industry.
Nov 06 2020
Cottonwood Technology Fund announces new VC fund; plans to invest in North European tech startups
Allen & Gledhill, TMI Associates, Haiwen & Partners and YKVN have advised Nanofilm Technologies International on its S$470.1 million ($346 million) initial public offering on the Singapore Exchange Securities Trading (SGX-ST), with Allen & Overy and JunHe counselling the issue managers and bookrunners.
In 2018, the U.S. Department of Energy established LaserNetUS, a network of facilities operating ultrapowerful lasers. Organized and funded through DOE’s Office of Fusion Energy Sciences (FES), the new network was created to provide vastly improved access to unique lasers for researchers, and to help restore the U.S.’s once-dominant position in high-intensity laser research. Now, new DOE funding totaling $18 million, including $1 million for user support, will be distributed among 10 partner institutions and will continue and expand LaserNetUS operations for three years.
Nov 01 2020
LaserNetUS High-Power Laser Consortium, Including Berkeley Lab, Receives $18M From the U.S. DOE
On October 27, 2020, the U.S. National Nanotechnology Initiative published the National Nanotechnology Initiative Supplement to the President’s 2021 Budget (Supplement), which serves as the annual report for NNI, called for under the provisions of the 21st Century Nanotechnology Research and Development Act. According to the Supplement, the President’s 2021 budget requests more than $1.7 billion for NNI, with an increased investment in the foundational research intended to lead to discoveries that will advance a wide range of areas.
Oct 27 2020
NNI Publishes Supplement to President’s 2021 Budget Request
Before diving into nanotech stocks to watch it’s important to consider what “nano” is and what it promises. Nano means billionth. Micro, which we are more familiar with, means millionth. Thus, nanotech exists on a scale 1,000 times smaller than the scale on which microtechnology does. Because of this, companies that compete in nanotechnology represent revolutionary advancements.
China will intensify support for basic research and aim for more breakthroughs in the area, a Chinese official said on Wednesday. Research is key to a country's scientific and technological innovation ability, and China will give higher priority to basic research and its applications, Wang Zhigang, Minister of Science and Technology, told a press conference.
Eden Prairie, Minn., Oct. 21, 2020 (GLOBE NEWSWIRE) -- NVE Corporation (Nasdaq: NVEC) announced today financial results for the quarter and six months ended September 30, 2020. Total revenue for the second quarter of fiscal 2021 decreased 33% to $4.38 million from $6.50 million for the the prior-year quarter. The decrease was due to a 33% decrease in product sales and a 29% decrease in contract research and development revenue. Net income for the second quarter of fiscal 2021 decreased 42% to $2.22 million, or $0.46 per diluted share, compared to $3.82 million, or $0.79 per share, for the prior-year quarter.
Oct 21 2020
NVE Corporation Reports Second Quarter Results and Announces Quarterly Dividend
Advanced NanoTherapies, Inc., a privately-held medical device company committed to exploring nanotechnology for enhanced drug uptake and sustained retention, today announced it has closed on the final tranche of its seed-round financing for a total of $5.3 million as a result of achieving a successful pre-clinical milestone. Funding came from a variety of angel investment sources in the US, Canada, Europe, Asia, and the Middle East, including venture funding from Cleveland Clinic and ForMed Ventures of Taiwan.
Oct 13 2020
Advanced NanoTherapies Raises $5.3 Million in Seed-Round Financing